logo
Select company
Select metric
4.04Current Ratio
VS
Market
78
Sector
57
Industry
83
History
83
$ 4.3Close
$ 1.96 - $ 4.3 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 26.84M4.04$ 6.65M
3/31/2025$ 36.26M3.75$ 9.68M
12/31/2024$ 11.76M1.62$ 7.28M
9/30/2024$ 4.79M0.53$ 9.09M
6/30/2024$ 9.97M1.38$ 7.2M
3/31/2024$ 6.54M0.78$ 8.33M
12/31/2023$ 10.7M1.49$ 7.19M
9/30/2023$ 16.92M2.11$ 8.03M
6/30/2023$ 20.98M2.74$ 7.67M
3/31/2023$ 15.65M1.66$ 9.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 1.35.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average Current Ratio has been 2.4.
  • The median Current Ratio for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was 2.11
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest Current Ratio over the past 5 years at 6.49.
  • The lowest Current Ratio recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe 0.53

INSIGHT MOLECULAR DIAGNOSTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
VNRX : VOLITIONRX LTD 0.35ARMP : ARMATA PHARMACEUTICALS INC 0.06CBUS : CIBUS INC 1.78PYXS : PYXIS ONCOLOGY INC 5.65NTRB : NUTRIBAND INC 4.78PRPH : PROPHASE LABS INC 0.96LUCD : LUCID DIAGNOSTICS INC 1.15PSTV : PLUS THERAPEUTICS INC 1.26BNBX : APPLIED DNA SCIENCES INC 2.76ALGS : ALIGOS THERAPEUTICS INC 6.31

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for INSIGHT MOLECULAR DIAGNOSTICS INC is calculated as follows: AssetsC [ $ 11.97M ] / LiabilitesC [ $ 8.9M ]
(=) Current Ratio [ 1.35 ]

IMDX - Current Ratio, Last 5 years

0.53

Minimum

Sep 30, 2024

6.49

Maximum

Mar 31, 2021

2.4

Average

2.11

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44